Evaluation of ABSOLVE in Diabetic Foot Ulcers

Summary

ABSOLVE Biologic Wound Matrix is a combination of recombinant human platelet-derived growth factor BB homodimer (rhPDGF-BB) and a bovine type I collagen wound dressing matrix. ABSOLVE is under development for the treatment of chronic and acute wounds. This study investigates the safety and efficacy of ABSOLVE in chronic diabetic foot ulcers (DFUs).

Timeline

Start

2017-01-30

Primary completion

2017-08-15

Completion

2017-10-15

Drugs

Indications